Vitiligo Prevalence and Patient Burden

John E. Harris, MD, PhD, reviews factors that shape prevalence of vitiligo and also explores the impact of vitiligo on patient quality of life.

Related Videos
John Harris, MD, PhD: Advancing Vitiligo Care After Ruxolitinib Cream
John Harris, MD, PhD: Year 1 of Ruxolitinib Cream for Vitiligo
Brett King, MD, PhD: Following Up the Ruxolitinib Cream Approval for Vitiligo
Related Content

Oral Povorcitinib Significantly Improves Total, Facial Vitiligo in 24 Week Trial

March 22nd 2023

What Ruxolitinib Cream Meant For Dermatology in 2022

December 20th 2022

Ruxolitinib Cream Maintains Vitiligo Facial Repigmentation At 2 Years

March 18th 2023

FDA Approves Ruxolitinib: New Horizons in Vitiligo Care

July 21st 2022

Microneedling, 5-Fluorouracil More Efficient Than Tacrolimus Monotherapy for Vitiligo

February 3rd 2023

Study Suggests Chemical Exposure May Contribute to Vitiligo Occurrence

January 5th 2023

Oral Povorcitinib Significantly Improves Total, Facial Vitiligo in 24 Week Trial

March 22nd 2023

What Ruxolitinib Cream Meant For Dermatology in 2022

December 20th 2022

Ruxolitinib Cream Maintains Vitiligo Facial Repigmentation At 2 Years

March 18th 2023

FDA Approves Ruxolitinib: New Horizons in Vitiligo Care

July 21st 2022

Microneedling, 5-Fluorouracil More Efficient Than Tacrolimus Monotherapy for Vitiligo

February 3rd 2023

Study Suggests Chemical Exposure May Contribute to Vitiligo Occurrence

January 5th 2023

Oral Povorcitinib Significantly Improves Total, Facial Vitiligo in 24 Week Trial

March 22nd 2023

What Ruxolitinib Cream Meant For Dermatology in 2022

December 20th 2022

Ruxolitinib Cream Maintains Vitiligo Facial Repigmentation At 2 Years

March 18th 2023

FDA Approves Ruxolitinib: New Horizons in Vitiligo Care

July 21st 2022

Microneedling, 5-Fluorouracil More Efficient Than Tacrolimus Monotherapy for Vitiligo

February 3rd 2023

Study Suggests Chemical Exposure May Contribute to Vitiligo Occurrence

January 5th 2023
© 2023 MJH Life Sciences

All rights reserved.